Mark Belkin to Mineralocorticoid Receptor Antagonists
This is a "connection" page, showing publications Mark Belkin has written about Mineralocorticoid Receptor Antagonists.
Connection Strength
0.197
-
A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction. ESC Heart Fail. 2021 10; 8(5):3495-3503.
Score: 0.197
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.